UK markets closed

Bactiguard Holding AB (publ) (0QV2.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
74.00+12.00 (+19.35%)
At close: 10:02AM BST

Bactiguard Holding AB (publ)

Vasagatan 11
2nd Floor
Stockholm 111 20
Sweden
46 84 40 58 80
https://www.bactiguard.com

Sector(s)
Industry
Full-time employees217

Key executives

NameTitlePayExercisedYear born
Ms. Christine LindChief Executive OfficerN/AN/A1974
Mr. Patrick Fruergaard BachChief Financial OfficerN/AN/A1983
Mr. Mikael SanderChief Operating OfficerN/AN/A1959
Mr. Sathish SubramaniamChief Technology OfficerN/AN/A1979
Ms. Nina NornholmHead of Corporate Communication & Investor RelationsN/AN/A1967
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Bactiguard Holding AB (publ), a medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. The company's infection prevention solutions reduce the risk of infections and the use of antibiotics. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of catheter related bloodstream infection and antibiotics; BIP Endotracheal Tube, that reduces the ventilator associated pneumonia, antibiotics, and healthcare costs; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention. The company's products also include Hydrocyn aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. In addition, it offers ZNN Bactiguard, an orthopedic trauma implants with infection prevention technology; and Aniocyn, a wound and skin care products for dogs, cats, horses, and other pets. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Stockholm, Sweden.

Corporate governance

Bactiguard Holding AB (publ)’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 8; Board: 8; Shareholder rights: 10; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.